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Executive Summary 
and Recommendations 
I. Introduction 
This document is a revision of the "Guidelines for the 
Clinical Application of Echocardiography" published in De-
cember 1990. This executive summary and recommendations 
appears in the March 15, 1997, issue of the loumal of the 
American College of Cardiology. The guidelines in their en-
"ACC/AliA Guidelines for the Clinical Application of Echocardiography" 
waF ::;;pfoved by the American College of Cardiology Board of Trustees in 
October 1996 and by the American Heart Association Science Advisory and 
Coordinating Committee in December 1996. These guidelines have been en-
dorsed by the American Society of Echocardiography. 
When citing this document, the American College of Cardiology requests 
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WF, Aurigemma GP, Beller GA, Bierman FZ, Davidson TW, Davis JL, Douglas 
PS, Gillam LD, Lewis RP, Pearlman AS, Philbrick JT, Shah PM, Williams RG. 
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tirety, including the ACC/AHA Class I, II, and III recommen-
dations, are published in the March 18, 1997, issue of Circu-
lation. Reprints of both the full text and the executive summary 
and recommendations are available from both organizations. 
With advanr,es in technology, the development of Doppler 
echocardiography, color Doppler, stress Doppler echocardiog-
raphy, ami transesophageal echocardiography (TEE), there 
has beell an increase in the clinical application of echocardi-
ography in the diagnosis of all forms of heart disease. The 
Committee on Clinical Application of Echocardiography, 
which is composed of experts in the field of echocardiographj', 
senior clinical cardiologists, and generalists, conducted a l>YS-
tematic search of the literature and reviewed the indications 
A single reprint of the executive summary and recommendations is available 
by calling 800-253-4636 (US only) or by writing the American College of 
Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 
20814-1699. Ask for reprint No. 71-0103. To obtain a reprint of the full tel(t 
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purchase additional reprints (specil)' version and reprint number): up to 999 
copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, 
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for the use of Doppler echocardiography in the diagnosis and 
evaluation of cardiovascular disease. Through a Medline 
search the committee obtained and considered more than 
3000 references from 1990 to 1995. The guidelines include 
recommendations for the use of Doppler eChocardiography in 
both specific cardiovascular diseases and in the evaluation of 
patients with frequently observed cardiovascular symptoms and 
signs such as dyspnea, chest discomfort, and cardiac murmurs. 
The recommendations concerning the use of Doppler echo-
cardiography follow the classification system used in other 
ACC/AHA guidelines. 
Class I: Conditions for which there is evidence and/or 
general agreement that a given procedure or treatment is 
useful and effective. 
Class 11: Conditions for which there is conflicting evidence 
and/or a divergence of opinion about the usefulness/;fficacy of 
a procedure or treatment. 
Class IIa: Weight of evidence/opinion is in favor of useful-
ness/efficacy. 
Class lIb: Usefulness/efficacy is less well established by 
evidence/opinion. 
Class III: Conditions for which there is evidence dnd/or 
general agreement that the procedure/treatment is not useful! 
effective find in some cases may be harmful. 
Evaluation of the clinical utility of a diagnostic test such 
as echocardiography is far more difficult than as~essment of 
the efficacy of a therapeutic intervention, because the 
diagnostic test cannot have the same direct effect on patient 
survival or recovery. Furthermore, there are no double-
blind randomized studies to prove the usefulness of the 
technique in a given situation. When studies assessing the 
sensitivity, specificity, and diagnostic accuracy of the tech-
nique were found in the literature, the strength of that 
evidence was weighed by the committee and designated Class 
I, II, or III. 
With a noninvasive diagnostic study that has no known 
complications, the potential exists for repeating the study 
unnecessarily. It is easier to state when a repeat echocardio-
gram is not ueeded than when and how often it should 
be repeated, because no studies in the literature address 
this question. An attempt by expert consensus has been 
made to indicate when and whether a study should be 
repeated. 
II. Murmurs and Valvular Heart Disease 
The basic indispensable evaluation of the patient with sus-
pected valvular disease remains the cardiovascular history and 
physical examination. Echocal'diography is extremely useful, how-
ever, in assessing the patient \vith a murmur. In tt0 evaluation of 
heart murmurs, an echocardiogram is used to 
o Define the primary lesion, its etiology, and estimated severity. 
• Define the hemodynamics. 
.. Detect coexisting abnormalities. 
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• Detect lesions ~e~ondary to the primary lesion. 
• Evahate cardiae size and function. 
o Establish a reference point for future observation. 
• Reevaluate the patient after an intervention. 
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Indications for Echocardiography in the Evaluation of 
Heart MUnllllr8 Class 
1. A munnur in a patient with cardiorespiratory 
symptoms. 
2. A munnur in an asymptomatic patient if the 
clinical features indicate at least a moderate 
probability that the murmur is reflective of 
structural heart disease. 
3. A munnur in an asymptomatic patient in whom 
there is a low probability of heart disease but in 
whom the diagnosis of heart disease cannot be 
reasonably excluded by the standard 
cardiovascular clinical evaluation. 
I 
I 
IIa 
4. In an adult, an IIsymptomatic heart murmur that 
has been identified by an experienced obsener as 
functional or innocent. 
ill 
Native Valvular Stenosis 
Two-dimensional Doppler echocardiography correctly as-
sesses stenotic lesions of both native and prosthetic valves. 
When the acoustic windows for transthoracic echocardiogra-
phy (TIE) are limited, TEE is effective. 
Indicatiolls for EcllOcardiography in 
Valvular Stenosis Class 
1. Diagnosis; assessment of hemodynamic severity. I 
2. Assessment of left ventricular (LV) and right I 
ventricular (RV) size, function, and/or 
hemodynamics. 
3. Reevaluation of patients ,,1th known vlllvular I 
stenosis with changing symptoms or signs. 
4. Assessment of changes in hemodynamic severity I 
and ventricular compensation in patients with 
known valvular stenosis during pregnancy. 
5. Reevaluation of asymptomatic patients with I 
severe stenosis. 
6. Assessment of the hemodynamic significance of lIs 
mild to moderate valvular stenosis by stress 
Doppler echocardiography. 
7. Reevaluation of patients with mild to moderate lIa 
aortic stenosis with LV dysfunction or 
hypertrophy even without clinical symptoms. 
8. Reevaluation of patients ~·ith mild to moderate lIb 
aortic valvular stenosis with stable signs and 
symptoms. 
9. Routine reevaluation of asymptomatic adult ill 
patients with mild aortic stenosis having stable 
physical signs and normal LV size and function. 
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10. Routine reevaluation of asymptomatic patients III 
with mild to moderate mitral stenosis and 
stable physical signs. 
(See also "Indications for Echocardiography in Interventions for 
Valvular Heart Disease and Prosthetic Valvcs.") 
Native Valvular Regurgitation 
Doppler echo cardiography is the most sensitive technique 
for detection of native valvular regurgitation. However, care 
must be taken to distinguish physiological phenomena from 
pathological lesions. Although significant v::!vular regurgita-
tion can be silent on auscultation, it is most ofter: seen in 
symptomatic, even hemodynamicalIy unstable patients. Silent 
valvular regurgitation discovered only by Doppler echocardi-
ography is usuaIly found in normal subjects and if trivial is 
considered to be within the range of normal. It is therefore 110t 
indicated to use echocardiography "to exclude valvular heart 
disease" in an asymptomatic patient with a normal physical 
examination. 
Because there is no accepted gold standard for assessing the 
severity of valvular regurgitation-not even angiocardio-
graphy-it is difficult to assess precisely the severity of the 
regurgitant lesion. Nonetheless, a number of Doppler echocar-
diography findings are useful in assessing severity. 
Echocardiography is the best choice for following patients 
with hemodynamically significant valvular disease to determine 
the timing of operative intervention. TEE has been valuable in 
assessing the possibility of valve repair versus replacement in 
mitral regurgitation. 
The question of whether or how often to repeat the 
echocardiogram depends on the severity of the lesion. In 
general, in the absence of a change in clinical condition, repeat 
echocardiography is not indicated in lesions of mild hemody-
namic severity. In patients with moderate to severe hemody-
namic valvular regurgitation, Doppler echo cardiography 
should be repeated if there is a change in the physical 
condition. Without a change it is appropriate to repeat the 
echocardiogram once a year. 
Indications for EcllOcardiograplly ill Native 
Valvular Regurgitation Class 
1. Diagnosis; assessmcnt of hemodynamic severity. I 
2. Initial assessment and reevaluation (when I 
indicatcd) of LV and RV size, function, and/or 
hemodynamics. 
3. Reevaluation of patients with mild to I 
moderate valvular regurgitation with changing 
symptoms. 
4. Reevaluation of asymptomatic patients with I 
severe regurgitation. 
5. Assessment of changes in hemodynamic I 
severity and ventricular compensation in 
patients with known valvular regurgitation 
during pregnancy. 
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6. RCl:valuation of patients with mild to moderate I 
regurgitation with v~ntricular dilation without 
cliniclll symptoms. 
7. Assessment of the effects of medical therapy on I 
the severity of reb'llrgitation and ventricular 
compcnsation and function. 
8. Reevaluation of patients with mild to moderate lIb 
mitral regurgitation without chambcr dilation 
and without clinical symptoms. 
9. Recvaluation of patients with muderate aortic lIb 
regurgitation without chamber dilation and 
without clinical symptoms. 
10. Routine reevaluation in asymptomatic patients ill 
with mild valvular regurgitation having stable 
physical signs and nonnal LV size and function. 
(See also "Indications for Echocardiography in Interventions for 
Valvular Heart Disease am! Prosthetic Valves.") 
Mitral Valve Prolapse 
The physical examination remains the optimal method for 
detecting the presence of mitral valve prolapse (MVP), and in 
the absence of physical findings in the supine, sitting, and 
standing positions, echocardiography is of little use as the 
primary means of diagnosing MVP unless there is supportive 
clinical evidence of structural heart disease or a family history 
of myxomatous valve disease. In patients with a nonejection 
click and/or murmur, an echocardiogram is useful for diagnosis 
and risk stratification, particularly by identifying leaflet thick-
ening and LV dilatation. 
h,dicatiolls for EcllOcardiograplzy IiI Mitral 
Valve Prolapse Class 
1. Diagnosis; assessment of hemodynamic severity, I 
leaflet morphology, and/or ventricular 
compensation in patients with physical signs of 
MVP. 
2. To exclude MVP in patients who have been lIa 
diagnosed but without clinical evidence to 
support the diagnosis. 
3. To exclude MVP in patients with first-degree IIa 
relatives with known ID)'Jl:Omatous valve disease. 
4. Risk stratification in patients with physical IIa 
signs of MVP or known MVP. 
5. Exclusion of MVP in patients with ill-defined III 
symptoms in the absence of a constellation of 
clinical symptoms or physical findings 
suggestive of MVP or a positive family history. 
6. Routine repetition of echocal'diography in III 
patients with MVP \\ltb no or mild 
regurgitation and no changes in clinical signs or 
symptoms. 
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Infective Endocarditis ill Native Valves 
Echocardiograpil) is useful for detection and characteriza-
tion of the hemodynamk and pathological consequences of 
infection, including valvular vegetations, regurgitant lesions, 
ventricular function, presence of ring abscesses, shunts, and 
r~ptured chordae. TEE is more sensitive in detecting vegeta-
tIons than TIE, but because of false-positive studies associated 
with rheumatic or mY'.<omatous valves, Lambl's excrescences 
etc, echocardiograpby does not supplant clinical and microbi~ 
ological diagnosis. Echocardiography is useful when there is a 
strong clinical suspicion of infective endocarditis with negative 
blood cultures or in patients with persistent unexplained 
bacteremia. 
Controversy remains as to whether echocardiographic 
characteristics of vegetations are useful in risk stratification' 
ie, predicting complications and mortality in the patien~ 
with infective endocarditis. In general, TEE is not indicated 
as the initial examination in the diagnosis of native valve 
infective endocarditis. TEE is indicated where TIE does not 
~dequately visualize the valve or answer hemodynamic ques-
tIOns. 
Illdicatiolls for Ec1lOcardiograplry in Infective 
Elldocartltis: Native Valves Class 
~ - ~r'~on :md characterization of valvular I 
.' 1he:r hemodynamic severity, and/or 
1llar compensation.* 
2. Ol > • 11 of vegetations and characterizations I 
of lesions in patients with congenital heart 
disease suspected of having infective 
endocarditis. 
3. Detection of associated abnormalities (eg, I 
abscesses, shunts, etc).* 
4. Reevaluation studies in complex endocarditis I 
(eg, virulent organism, severe Ilemodynamic 
lesion, aortic valve involvement, persistent fever 
or bacteremia, clinical change, or symptomatic 
deterioration). 
5. Evaluation of patients with high clinical I 
suspicion of' culture-negative endocarditis. * 
6. Evaluation of bacteremia without a known Ua 
source.* 
7. Risk stratification in established endocarditis.* IIa 
8. Routine reevaluation in uncomplkated lIb 
endocarditis during antibiotic therapy. 
9. Evaluation of fever and nonpathological III 
murmur witk:mt evidence of bacteremia. 
*TEE may provide incremental value ill addition to information 
obtained by ITE. The role of TEE in first-line examination 
awaits further study. 
Prosthetic Valves 
Prosthetic valves are subject to valvular degeneration, de-
velopment of valvular regurgitation and stenosis, thrombus, 
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and endocarditis. It is valuable to have a baseline postoperative 
study. for further comparison if a suspected problem arises, 
espeCially for evaluation of changes in ventricular function and 
hemodynamics after recovery from surgery. 
Indications Jor Ec1lOcardiogmpfly ill IllIerventions for 
Vaivillar Heart Disease and Prostlzetic Valves Class 
1. Assessment of the timing of valvular I 
intervention based on ventricular compensation, 
function, and/or severity of primary and 
secondary lesions. 
2. Selection of alternative therapies for mitral 
valve disease (such as balloon valvuloplasty, 
operative valve repair, valve replacement).* 
3. Use of echocardiography (especially TEE) in I 
performing intel'ventional techniques (eg, 
balloon valvotomy) for valvular disease. 
4. Postintervention baseline studies for valve I 
function (early) and ventricular remodeling 
(late). 
5. Reevaluation of patients with valve replacement I 
with changing clinical signs and symptoms; 
suspected prosthetic dysfunction (stenosis, 
regurgitation) or thrombosis.* 
6. Routine reevaluation study after baseline IIa 
studies of patients with va!ve replacements 
with mild to moderate ventricular dysfunction 
without changing clinical signs or symptoms. 
7. Routine reevaluation at the time of increased lIb 
failure rate of a biolJrosthesis witbout clinical 
evidence of prosthetic dysfunction. 
8. Ruutine reevaluation of patients with valve ill 
replacements without suspicion of valvular 
d,ysfunction and unchanged clinical signs and 
symptoms. 
9. Pati,mts whose clinical status precludes ill 
therapeutic interventions. 
*TEE may provide incremental value in addition to infonnation 
obtained by TTE. 
Indications Jar Ec1zocardiograplly in Infective 
Endocarditis: Prosthetic Valves Class 
1. Detection and characterization of valvular I 
lesions, their hemodynamic severity, and/or 
ventricular compensation. * 
2. Detecth:m of associated abnormalities (eg, I 
abscesses, shunts, etc).* 
3. Reevaluation in complex endocarditis (eg, I 
virulent organism, severe hemodynamic lesion, 
aortic valve involvement, persistent fever or 
bacteremid, clinical change, or symptomatic 
deterioration)_ * 
4. Evaluation of suspected endocarditis and I 
negative culiures.* 
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5. Evaluation of bacteremic without known source. * I 
6. Evaluation of persistent fever without evidence IIa 
of bacteremia or new munnur.* 
7. Routine reevaluation in uncomplicated lIb 
endocarditis during antibiotic therapy. * 
8. Evaluation of transient fever without evidence of 1II 
bacteremia or new munnur. 
*TEE may provide incremental value in additiun to that obtained 
byTfE .. 
III. Chest Pain 
Chest pain can result from cardiac and noncardiac causes. 
The most common clinical cardiac disorder presenting as chest 
pain is myocardial ischemia from coronary artery disease. 
Other cardiovascular disorders such as pericarditis, dissection 
of the aorta, and hypertrophic cardiomyopathy produce echo-
cardiographic findings that distinguish them from ischemic 
h~art disease and are described elsewhere in these guidelines. 
The role of e~nocardiography has increased over the last 5 
years where the chara\~ter of chest pain or its association with 
risk factors raises concern about coronary artery disease as the 
cause. Echocardiography C<i'1 confirm the presence of wall 
moticn abnormalities, which ~uggest myocardial ischemia 
and/or prior infarction, but does not always distinguish among 
these other possible cardiovascula.- disorders. In a patient with 
persistent chest pain, normal wall .'TIotion makes acute trans-
mural myocardial infarction less Iikdy. 
Indications for Echocardiography ill Pat/ellis With 
Che~t PD.in C!ass 
1. Diagnosis of underlying cardiac ',1isease m patients I 
with chest pain and clinical el,idence of valvular, 
pericardial, or primary my()l~ardiaQ disease (see 
sections fi, IV through VI, 'VIll, and IX). 
2. Evaluation of chest pain ;11 patien~s with I 
suspected llcute mY0C8r-.Jial ischemia, ,,,hen 
baseline ECG is nondiagtl(lstic and when study 
can be obtained during pain or soon after its 
abatement (see !lectiollJ lV). 
3. Evaluation of chest pain in patients with I 
suspected aortic dissection (see section VIll). 
4. Chtst pain in patients with severe hemodynamic I 
instability (see section XIll). 
5. Evaluation of chest pain for which a nonc~rdiac III 
etiology is apparent. 
6. Diagnosis of chest pain in a patient with III 
electrocardiographic changes diagnostic of 
myocardial ischemia/infarction. 
IV. Ischemic Heart Disease 
Echocardiography is a powerful tool for diagnosing the 
presence of coronary artery disease, assessing the amount of 
myocardium involved, and reaching a Pi ognosis. Echocardiog-
raphy can identify mechanical complications of acute myocar-
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dial infarction and differentiate causes of decreased cardiac 
output and blood pressure, such as extensive LV infarction 
versus hypovolemia, thus guiding therapy. Stress echocardiog-
raphy by either exercise or pharmacological stress testing can 
be used in detection of the presence, location, and severity of 
inducible myocardial ischemia as well as for risk stratification 
and prognosis. 
Acute lschemic Syndromes (Acute Myocardial 
Infarction and Unstable Angina) 
Echocardiography is most helpful in the diagnosis of acute 
ischemic syndromes when the clinical history and electrocar-
diographic findings are nondiagnostic. Segmental LV wall 
motion abnormalities are characteristic of myocardial infarc-
tion. However, regional wall motion abnormalities are seen 
in transient myocardial ischemia and chronic ischemIa (hiber-
nating myocardium) as well as scar tissue. Segmental wall 
motion abnormalities are also seen in myocarditis and cardio-
myopathy. In patients with prolonged chest pain, segmental 
LV wall abnormalities predict a high likelihood of acute 
myocardial infarction. In such patients the absence of segmen-
tal wall abnormalities or the presence of diffuse wall motion 
abnormalities has a high negative predictive value. Acute 
ischemia cannot be distinguished from acute my<'cardial ne-
crosis. In patients with unstable angina, atypical clinical his-
tory, and a norr.::al or nonspecific ·ECG, an echocardiogram 
recorded during chest pain may demont, nate reversible seg-
mental wall abnormalities and confirm the diagnosis of unsta-
ble angina. 
Echocardiography, performed at the bedside if necessary, 
can evaluate all complications of an acute myocardial infarc-
tion, such as acute mitral regurgitation, free wall rupture, 
ventricular septal rupture, intracardiac thrombosis, RV infarc-
tion, LV aneurysm formation, and pericardial effusion. 
By aiding in the early identification of acute myocardial 
infarction, its effect on LV function, and its complications, 
echocardiography may facilitate the prompt initiation of ap-
propriate therapy. 
Indieatiolls for Ec110eaI'diography ;n tlte Dwgnosis of 
Acute Myocardial Isellemie SYlldromes Ci..~s 
1. Diagnosis of suspected acute ischemia or I 
infarction not evident by standal'd means. 
2. Messurement of baseline LV function. I 
3. Patients with inferior myocardial infarction and I 
bedside evidence suggesting possible RV 
infarction. 
4. Assessment of mechanical complicati9ns and I 
mural thrombus.* 
5. Identification of location/severity of disease ill IIa 
patients with ongoing ischemia. 
6. Diagnosis of acute myocardial ir.fal'Ction alrecdy III 
evident by standard means. 
*TEE is indicated when TIE studies are ('ot diagnostic. 
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Predischarge Evaluation Using 
Stress Echocardiography 
Graded intravenous dobutamine stress echocardiography can 
be helpful in assessing myocardial viability and distinguish nonvi-
able myocardium from stunned myocardium when performed 2 
to 10 days after an acute myocardial infarction. Stunned and 
hibernating myocardium can respond to inotropic stimulation, 
and this response distinguishes viable from infarcted myocar-
dium. Myocardial segments with initial improvement during 
low-dose dobutamine infusion but deterioration of function with 
higher doses are supplied by arteries with significant stenoses. 
Augmentation of systolic wall thickening with higher doses of 
dobutamine denotes preserved viability and implies lack of critical 
stenosis in the infarct-related artery. 
Few late long-term event rates have been studied by predis-
charge stress echocardiography after acute myocardia! infarction 
both in those who have and those who have not had thrombolysis 
or other repetfusion therapy. Nevertheless, when patients cannot 
exercise for a variety of reasons, pharmacological stress echocar-
diography is a valuable alternative for evaluation of residual 
myocardium at risk. . 
In p;ttients with unstable angina and an ECG that is normal 
or shows nonspecific changes, echocardiography can reveal 
reversible segmental wall motion abnormalities during pain 
that an: characteristic of transient ischemia and can also show 
the coronary territory involved lind the size of the area a~ risk. 
Indications fur Edw:oFtIiograplzy ill Risk Assessment, 
Prognosis, and Avsessment of Therapy ill Acute 
Myocardial Ischemic SYlldromes Class 
1. Assessment of infarct size and/or rxtent of I 
jeopardized myocardium. 
2. In-hospital assessment of ventricill2r function 
when the results are used to guide :therapy. 
3. In-hospital or early postdischarge assessment of I 
th~ presence/extent of inducible ischemia 
wtenever baseline abnormalities are expecteri to 
compromise electrocardiographic interpretati;m. * 
4. In-hospital or early postdischarge assessment of IIa 
the presence/extent of inducible ischemia in the 
absence of baseline abli,.,malities expected to 
compromise ECG interpH~tation. * 
5. Assessment of myocardial viability when required IIa 
to define potential efficacy of revascularization.t 
6. Rccl'aluation of ventricular function during IIa 
re~overy when results are used to guide therapy. 
7. Assessment of ventricular function after ITa 
revascularization. 
8. Assessment of long-tenn prognosis (~2 years lIb 
after acute myocardi.lll infarction). 
9. Routine reevaluation in the absence of any ill 
change iiI clinical status. 
*Exercise or pharmacological stress echocardiogram. 
tDobutamine stress echocardiogram. 
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Chronic Ischemic Heart Disease 
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In patients with chronic ischemic heart disease, echocardi-
ography is useful in diagnosis, risk stratification, and clinical 
management decisions. 5chocardiographic imaging and Dopp-
ler techniques can assess LV systolic function, the most 
important determinant of prognosis, lis well 1\S diastolic func-
tion of the left ventricle. Resting echoc.,mliography can detect 
and estimate the severity of long-term structural and functional 
alterations seen in patients with coronary artery disease such as 
mitral regurgitation or LV aneurysm and in differentiating true 
aneurysm from false. 
Stress echocardiography by either exercise or pharmacolog-
ical challenge (using vasodilators or dobutamine) is both sensitive 
and specific for detecting inducible myocarriial ischemia in pa-
tients with intermediate to high pretest probability of coronary 
artery disease. Dobutamine stress echocardiography has a higJier 
sensitivity than vasodilator stress echocardiography for detecting 
coronary artery stenosis. Stress echocardiogIaphy, as with other 
noninvasive methods, has a higher sensitivity in patients with 
multivessel disease than in patients with one-vessel disease, in 
patients with prior myocardial infarction, and in those with> 70% 
stenosis compared with lesser degrees of coronary obstruction. In 
patients with moderate to high clinical suspicion of coronary 
artery disease, stress echocardiography, like other noninvasive 
techniques, is appropriate when standard exercise ECG testing is 
likely to be nondiagnostic, eg, in patients with resting ST-Twave 
changes, left bundle branch block, ventricular paced rhythms, LV 
hypertrophy, and taki~g digitalis, etc. Stress echocardiography is 
not recommended for screening asymptomatic patients for the 
presence of coronary t:lJ'iery disease because of the low pretest 
likelihood of disease. 
Illdicatiolts for Echocardtl.'gmplzy ill Diagnosis and 
Prognosis of Chronic Ischemic Heart Disease Class 
1. Diagnosis of myocardial ischemia in I 
symptomatic individuals. * 
2. Assessment of global ventricular function at rest. I 
3. Assessment of myocardial viability (hibernating I 
myocardium) for planning revascularization.t 
4. Assessment of functional significance of coronary I 
lesionr. (if not already known) in planning 
percutaneous translUniinal coronary 
angioplasty. * 
5. Diagnosis of myocardial ischemia in selected lIb 
patients with an intermediate or high pretest 
likelihood of coronary artery disease.* 
6. Assessment of an asymptomatic patient with lIb 
positive results from a screening treadmill te:i~. 
7. Assessment of global ventricular function with lIb 
exercise.* 
8. Screening of asymptomatic persons with a low ill 
likelihood of coronary artery disease. 
9. Routine periodic reassessment of stable patients ill 
for whom no change in therapy is contemplated. 
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10. Routine substitution for treadmill exercise III 
testing in patients for whom ECG analysis is 
t7Cpccted to suffice. 
"'Exercise or pharmacological stress echocarrlio;;:mnl. 
tDobutamine stress e!:hocardiogram. 
Other: Risk stratification befor~ noncardiac surgery. (See Eagle 
KA, Brundage BH, Chaitman BR, et al. ACC/AHA guidelines 
for perioperative cardiovascular e\'.llluation for noncardiac 
surgery. J Am Coli Cardio! 1996;27:910-48.) 
Myocardial Viability in Chronic Coronaty 
AI1ery Disease 
In patients with chronic coronary artery disease, myocardial 
contractile fUllction can be impaired because of irreversible 
necl'J~is or scar tissue or as a result of "hibernating" myocardium 
tbat can improve with revascularizalion. Improvemef1t of S':'gmen-
tal function during dobutamine stress echocardiogral~~y indicates 
contractile reserve and viability and predicts the lu<:cli!:\ood oi 
improved ventricular function after revascularization. 'I'll!.; lack of 
contractile reserve during dobutamine infusion denoies a low 
likelihood of improvement after revascularization. To detect 
hibernating myocardium in patients with chronic LV dysfunction, 
larger studies using dobutamine stress echocardiography are 
needed. Patients would then undergo revascularization to confirm 
the predictive value of test results. 
Echocardiographic Assessment Before and 
After Revascularization 
Echocardiography can be helpful in planning for revascu-
larizadon procedures by demcnsti'ating the functional signifi-
cance of a given coronary stenosis. This is especially important 
in determining the need for catheter-based revascularization. 
Stress echocardiography is useful for detecting restenosis in 
patients who become symptomatic after catheter revascular-
ization and can be used when standard exercise tests are not 
possible because of deconditioning, physical disability, or 
difficulty interpreting the ECG. After surgical or catheter 
revascularization, routine follow-up testing is generally not 
necessary in the asymptomatic patient. 
Indications for Echocardiography in Assessment of 
Interventions in Chronic Ischemic Heart Disease Class 
1. Assessment of LV function when needed to guide I 
institution arid modification of drug therapy in 
patients with knmm or suspected LV dysfunction. 
2. Assessment for restenosis after revascularization I 
in patients with atypical recurrent 5ymptoms. * 
3. Assessment for restenosis after revascularization ITa 
in patients with typical recurrent symptoms. * 
4. Routine assessment of asymptomatic patients m 
after revascularization. 
*Exercise or pharmacological stress echocardiogl'3phy. 
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V. Cardiomyopathy and Assessment of 
Left Ventricular Function: 
Echocardiographic Parameters 
Left Ventricular Size, Wall Thickness, Mass, and 
Systolic Function 
Evaluation of LV systolic function is among the most 
common reasons for requesting echocardiography. LV short-
ening fraction, systolic and diastolic volumes, and LV mass can 
be accurately assessed by two-dimensional echocardiography. 
Septal and posterior LV thicknesses can be accurately mea-
sured by M-mode echo cardiography. There is extensive and 
excellent support for these measurements in the literature. 
LV ejection fraction can be assessed with two-dimensional 
echocardiography. The algorithms used vary in complexity. In 
general, all are suitable for normally shaped and normally 
contracting left ventricles. More complex approaches are 
needed to assess deformed left ventricles with regional wall 
motion abnormalities. Visual estimation of ejection fraction 
from two-dimensional echocardiography is common and accu-
rate when the reader is experienced, but it is subjective and 
therefore less reproducible than quantitative methods. Echo-
cardiography is well-suited for the qualitative assessment of 
regional LV contractile function. 
Edema and Dyspnea 
Peripheral edema has numerous causes, both cardiac and 
noncardiac. Peripheral edema results from any c~.rdiac or 
pericardial disease that causes an elevation in central venous 
pressure. Echocardit:graphy generally provides the diagnosis. 
The overlapping features of constrictive pericarditis and re-
strictive cardiomyopathy may make definite diagnosis by echo-
cardiography difficult. In the absence of an elevation in central 
venous pressure, a cardiac or pericardial reason for peripheral 
edema is usually not present, and echo cardiography is not 
recommended. 
Dyspnea, one of the cardinal symptoms of heart failure, is 
often rel?ted to elevation of pulmonary venous pressure. 
Dyspnea can also be due to noncardiac causes, such as 
neuromuscular disease, pulmonary disease, central nerv.ous 
system disease, and anemia~ Echocardiography can help iden-
tify cardiac causes of dyspnea by identifying valvular, coronary, 
myocardial, or pericardial disease. 
Dilated Cardiomyopathy 
Echocardiography demonstrates dilated ventricular cham-
bers, usually with normal wall thickness and varying degrees of 
depressed systolic function in patients with dilated cardiomy-
opathy. Doppler techniques reveal the presence and magni-
tude of associated valvular regurgitation, allow estimation of 
pulmonary artery pressures, and offer insight into the diastolic 
function of the left ventricle. Echocardiography is valuable in 
following therapy with drugs known to depress LV function, 
such as doxorubicin. 
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Hypertrophic Cardiomyopathy 
Echocardiography provides a definitive diagnosis of hyper-
trophic cardiomyopathy by revealing ventricular hypertrophy 
without other primary causes. It l1lso permits assessment of the 
distribution of hypertrophy, the presence and magnitUde of 
obstructive gradients across the LV outflow tract, the presence 
and severity of mitral regurgitation, and the evaluation of 
diastolic filling. It can be useful for assessing the effects of both 
medical and surgical therapy. 
Restrictive Cardiomyopathy 
Echocardiography usually reveals normal ventricular size 
and systolic function with atrial enlargement in patients with 
restricted cardiomyopathy. Doppler studies demonstrate char-
acteristic inflow velocity profiles. Intense echo cardiography 
reflectance gives a characteristic stippled appearance in some 
cases of amyloidosis abnormalities. 
Heart Failure With Normal Systolic Function 
(Diastolic Dysfunction) 
Diastolic dysfunction is thought to be present when a 
patient with heart failure has an LV ejection fraction >40%. 
Because treatment and prognosis for heart failure due to 
predominant diastolic dysfunction may differ from that of 
heart failure due to systolic dysfunction, the proper diagnosis is 
critical. Because of the effect of heart rate and loading 
characteristics on diastolic function and the inability to apply 
the Doppler indexes in atrial fibrillation and other rhythm and 
conduction disturbances, echocardiographic indexes of dia-
stolic function must be interpreted in the context of all 
potential confounding clinical variables. 
Evaluation of the Right Ventricle 
Quantitation of RV size and volume are more problematic 
than comparable measurements of the left ventricle due to the 
complex shape of the right ventricle, its heavy trabecular pattern, 
and difficulty obtaining standardized imaging planes. Assessment 
of the size and function of the right ventricle is therefore usually 
performed in a qualitative fashion. Echocardiographic methods 
of evaluating RV diastolic function are less validated. 
Indicatiolls for Ecllocardiograplly ill Patients With 
Dyspnea, Edema, or Cardiomyopathy Class 
1. Assessment of LV size and functian in patients 
with suspected cardiomyopathy or clinical 
diagnosis of heart faiIure.* 
2. Edema with clinical signs of elevated central 
venous pressure when a potential cardiac 
etiology is suspected or when central venous 
pressure cannot be estimated with confidence 
and clinical suspicion of heart disease is 
high.* 
I 
I 
ECHOCARDIOGRAPHY GUIDELINES 
ACC/AHA TASK FORCE 
3. Dyspnea with clinical !'igns of heart disease. I 
4. Patients with unexplained hypotension, I 
especially in the intensive care unit.* 
5. Patients exposed to cardiotoxic agents, to I 
determine the advisability of additional or 
increased dosages. 
6. Reevaluation of LV function in patients with I 
established cardiomyopathy when there has 
been a documented change in clinical status or 
to guide medical therapy. 
869 
7. Reevaluation of patients with established lIb 
cardiomyopathy when there is no change in 
clinical status. 
8. Reevaluation of patients with edema when a lIb 
potential cardiac cause has already been 
demonstrated. 
9. Evaluation of LV ejection fraction in patients III 
with recent (contrast or radionuclide) 
angiographic determina~ion of ejection fraction. 
10. Routine reevaluation in clinically stable patients III 
in whom no change in management is 
contemplated. 
11. In patients with edema, normal venous III 
pressure, and no evidence of heart disease. 
*TEE is indicated when TTE studies arc not diagnostic. 
VI. Pericardial Disease 
The earliest clinical application of echocardiography was 
detection of pericardia! effusion. Echocardiography rl'mains 
the best technique for evduating this condition. 
Pericardial Effusion 
The presence, amount, and distribution of pericardial fluid 
can be demonstrated by echocardiography. The presence of 
fibrous strands, tumor masses, and blood clots can also be 
shown. Although most pericardia! effusions requiring pericar-
diocentesis are located anteriorly and posteriorly, loculated 
effusions can occur, particularly after cardiac surgery. In these 
cases echocardiography can define the distribution of the fluid 
so the safest and most effective approach can be planned for 
pericardiocentesis. 
Cardiac Tamponade 
Although the diagnosis of cardiac tamponade is based on 
established clinical criteria, an accurate and early diagnosis can 
be made by echo cardiography. Right atrial collapse is sensitive, 
but diastolic RV collapse is a more specific sign for cardiac 
tamponade. Distention of the inferior vena cava that does not 
collapse on deep inspiration indicates an elevation in central 
venous pressure. Characteristic Doppler inflow patterns have 
been well validated. 
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Constrictive Pericarditis 
Echocardiographic abnormalities are always present. No 
single echocardiographic sign is diagnostic of constrictive 
pericarditis. Perir:ardial thickening, inferior vena caval enlarge-
ment, mild atrial enlargement with normal-sized left ventricle, 
and abnormalities of septal m )tion can all be present. Doppler 
findings of exaggerated respiratory variation in flow velocities 
across the atrioventricular valves as well as LV outflow and 
pulmonary venous flow are highly characteristic. 
Indications for EcllOcardiography in 
Pericardial Disease Class 
1. Patients with suspected pericardial disease, I 
including effusion, constriction, or 
elfusive·constrictive process. 
2. Patients with suspected bleeding in the I 
pericardial space, eg, trauma, perforation, etc. 
3. Follow.up study to evaluate recurrence of I 
effusion or to diagnose early constriction. Repeat 
studies may be goal directed to answer a specific 
clinical question. 
4. Pericardial friction rub developing in acute I 
myocardial infarction accompanied by symptoms 
such as persistent pain, hypotension, and nausea. 
5. Follow·up studies to detect early signs of IIa 
tamponade in the presence of large or rapidly 
accumulating elfusions. A goal.directed study 
may be appropriate. 
6. Echocardiographic guidance and monitoring of IIa 
pericardiocentesis. 
7. Postsurgical pericardial disease, including lIb 
postpericardiotomy syndrome, with potential for 
hemodynamic impairment. 
S. In the presence of a strong clinical suspicion and rIb 
nondiagnostic TIE, TEE assessment of 
pericardial thickness to support a diagnosis of 
constrictive pericarditis. 
9. Routine follow-up of small pericardial effusion in III 
clinically stable patients. 
10. Follow-up studies in patients with cancer or III 
other terminal illness for whom management 
would not be influenced by echocardiographic 
findings. 
11. Assessment of pericardial thickness in patients III 
without clinical evidence of constrictive 
pericarditis. 
12. Pericardial friction rub in early uncomplicated III 
myocardial infarction or early postoperative 
period after cardiac surgery. 
VII. Cardiac Masses and Tumors 
Echocardiography is an accurate high-resolution technique 
for identifying masses within any of the four cardiac chambers. 
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These masses include primary tumors of the heart (the most 
common of which is atrial myxoma), as well as metastatic 
tumors, thrombi, and valvular vegetations. Intracardiac masses 
should be suspected in the context of clinical presentation, eg, 
suspicion of valvular vegetations with underlying connective 
tissue diseases or clinical signs of infective endocarditis. Pa-
tients with rheumatic heart disease are predisposed to devel-
oping intracardiac masses, dilated cardiomyopathy, atrial fi-
brillation, and anteroapical myocardial infarction, as are 
patients with malignancies known to have a high incidence of 
cardiovascular involvement, such as hypernephroma and met-
astatic melanoma. In patients with peripheral embolic phe-
nomena such as embolic stroke, an intracardiac mass should be 
suspected if another source is not identified. 
Indications for Echocardiography in Patients Witlt 
Cardiac Masses and Tumors Class 
1. Evaluation of patients with clinical syndromes I 
and events suggesting an underlying cardiac 
mass. 
2. Evaluation of patients with underlying cardiac I 
disease known to predispose to mass formation 
for whom a therapeutic decision regarding 
surgery or anticoagulation will depend on the 
results of echocardiography. 
3. Follow-up or surveillance studies after surgical I 
removal of masses known to have a high 
likelihood of recurrence (ie, myxoma). 
4. Patients with known primary malignancies when I 
echocardiographic surveillance for cardiac 
involvement is part of the disease staging 
process. 
5. Screening persons with disease states likely to lIb 
result in mass formation but for whom no 
clinical evidence for the mass exists. 
6. Patients for whom the results of III 
echocardiograpby will bave no impact on 
diagnosis or clinical decision making. 
VIII. Diseases of the Great Vessels 
TIE and TEE can effectively visualize the entire thoracic 
aorta, except for a smaIl segment of the upper ascending 
portion adjacent to the tracheobronchial tree. The main and 
proximal right and left pulmonary arteries can also be visual-
ized as weIl as the proximal portions of the superior vena cava, 
innominate vein and upper inferior vena cava, proximal seg-
ments of the hepatic veins, and pulmonary veins. 
Aortic Dissection, Aneurysm, Rupture, and 
Thoracic Aortic Degenerative Disease 
In some patients with type I and II dissection involving the 
proximal ascending aorta, TIE can visualize the intimal flap 
and determine the degree of pericardial effusion and aortic 
.IACC Vol. 29, No.4 
Murch 15. J 997:H62-79 
regurgitation. However, TEE is a far more sensitive and 
specific diagnostic procedure. Because time is extremely im-
portant, only an abbreviated TIE is done before TEE. Biplane 
or multiplane TEE should be used for comprehensive and 
accurate visualization of the thoracic aorta. 
Aneurysms of the ascending aorta can be characterized by 
TIE. With Doppler, rupture of an aneurysm of the sinus of 
Val salva as well as the communicating cardiac chamber can be 
identified. TEE is often necessary to ?dequately visualize 
descending thoracic aortic aneurysms. 
TEE is useful for identifying traumatic and other causes of 
aortic rupture. However, small tears can be overl -;oked. 
TEE can detect atheromatous debris, clots, and other 
lesions capable of producing downstream embolic occlusion in 
thoracic aortic dzgenerative disease. 
Class 
Indications for Echocardiography in Suspected 
11lOracic Aortic Disease 1TE TEE 
1. Aortic dissection. IIa I 
2. Aorl;c aneurysm. 1* I 
3. Aortic rupture. lIb I 
4. Aortic root dilatation in Marfan or I lib 
other connective tissue syndromes. 
5. Degenerative or tr-uumatic aortic disease lIb I 
with clinical atheroembolism. 
6. Follow-up of aortic dissection, especially I IIa 
after surgical repair without suspicion 
of complication or progression. 
7. Follow-up of aortic dissection especially IIa I 
after surgical repair when complication 
or progression is suspected. 
8. First-degree relative of a patient with I lIb 
Marfan syndrome or other connective 
tissue disorder. 
*Espccially for aortic root aneurysm. 
The Great Veins 
EChocardiography is useful for visualizing the superior vena 
cava and diagnosing some congenital and acquired abnormal-
ities such as persistent left superior vena cava and its connec-
tion to the coronary sinus. Together with Doppler, TIE and 
TEE can detect thrombi, tumors, the size and connection of 
the hepatic veins, superior vena cava, and pulmonary veins as 
well as flow dynamics in these veins. 
IX. Puimonary Disease 
Patients with pulmonary disease generally are not ideal 
candidates for echocardiographic examination because the 
hyperinflated lung is a poor conductor of ultrasound. In most 
patients with pulmonary disease, the subxiphoid or subcostal 
view can visualize the heart well. Between these TIE windows 
and TEE, it is possible to obtain an echocardiographic image 
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of the heart and vessels in almost all patients with primary lung 
disease. 
Although a normal echocardiogram does not indicate a 
diagnosis of lung disease, the differential diagnosis of cardiac 
versus pulmonary symptoms often can be made on the basis of 
a normal echocardiogram. If lung disease is the cause of 
pulmonary hypertension, the echocardiogram can detect dila-
tation, hyper~rophy, or hypokinesia of the right ventricle. If 
tricuspid regurgitation is present, Doppler techniques can 
allow an estimation of pulmonary artery systolic pressure. 
Echocardiography may aid in the diagnosis of severe or 
massive pulmonary embolism but otherwise has low sensitivity 
and specificity in detecting pulmonary emboli. 
Indications for Echocardiograplly in 
PlIlmonary Disease Class 
1. Suspected pulmonary hypertension. I 
2. Pulmonary emboli and suspected clots in the I 
right atrium or ventricle or main pulmonary 
artery branches.* 
3. For distinguishing cardiac versus non cardiac I 
etiology of dyspnea in patients in whom all 
clinical and laboratory clues are ambiguous.* 
4. Follow-up of pUlmonary artery pressures in I 
patients with pulmonary hypertension to 
evaluate response to treatment. 
5. Lung disease with clinical suspicion of cardiac I 
involvement (suspected cor pulmonale). 
6. Measurement of exercise pulmonary artery lIa 
pressure. 
7. Patients being considered for lung lIa 
transplantation or other surgical procedure for 
advanced lung disease. * 
8. Lung disease without any clinical suspicion of ill 
cardiac involvement. 
9. Reevaluation studies of RV function in patients ill 
with chronic ohstructive lung disease without a 
change in clinical status. 
*TEE is indicated when TIE stUdies are not diagnostic. 
x. Systemic Hypertension 
Echocardiography is the best procedure to evaluate the 
cardiac effects of systemic hypertension, the most common 
cause of LV hypertrophy and congestive heart failure in adults. 
Detection of LV hypertrophy and estimation of LV mass are 
more sensitive and specific with echocardiography than either 
radiogmphy or echocardiography. Because echocardiographic 
detection of concentric hypertrophy is more sensitive than 
electrocardiography, and because concentric LV hypertrophy 
increases the risks of cardiac morbidity and mortality, a 
decision to initiate therapy may be based on the presence of 
LV hypertrophy. Therefore, in borderline hypertensive pa-
tients without evidence of LV hypertrophy on EeG, a goal-
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directed echocardiogram to evaluate LV hypertrophy may bc 
indicated. 
Although a decrease in LV mass in hypertensive patients on 
therapy has been demonstrated by cchocardiography, the value 
of repeat echocardiograms in asymptomatic hypertensive pa-
tients with normal LV function has not been established, 
because the impact of LV regression on patient morbidity and 
mortality is unknown. 
Indications for Ec1lOcardiography ill Hypertension Class 
1. When assessment of resting LV function, I 
hypertrophy, or concentric remodeling is 
important in clinical decision making (see LV 
function). 
2. Detection and assessment of functional 
significance of concomitant coronary artery 
disease (see coronary disease).* 
3. FoIlow-up assessment of LV size and function in I 
patients with LV dysfunction when there has 
been a documented change in clinical status or 
to guide medical therapy. 
4. Identification of LV diastolic filling IIa 
abnormalities with or without systolic 
abnormalities. 
5. Assessment of LV hypertrophy in a patient with IIa 
borderline hypertension without LV hypertrophy 
on ECG to guide decision making regarding 
initiation of therapy. A limited goal-directed 
echocal"diogram may be indicated for this 
purpose. 
6. Risk stratification for prognosis by lIb 
determination of LV performance. 
7. Reevaluation to guide antihypertensive therapy III 
based on LV mass regression. 
S. Reevaluation in asymptomatic patients to assess III 
LV function. 
*Stress echocardiography. 
XI. Neurological Disease and Other 
Cardioembolic Disease 
Acute interruption of blood flow to the cerebral vasculature 
or a peripheral artery results in clinical syndromes such as 
transient ischemic attacks, cerebrovascular accidents, and 
acute limb ischemia. The prevalence of a cardioembolic etiol-
ogy is highly variable but is the source in up to 20% of acute 
neurological events, with another 40% being cryptogenic and 
possibly cardioembolic in origin. Cause and effect is difficult to 
prove, with the exception of the link between an embolus in a 
patient with infective endocarditis and an embolus in a patient 
with a prosthetic valve. 
The most frequently evaluated cardioembolic events in the 
literature are acute neurologic'll syndromes. The level of 
evidence for causally linking a potential cardiac source of the 
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embolus to the neurological event is relatively low. The 
likelihood of a cardioembolic source depends on the clinical 
setting, with sudden onset of a middle or anterior cerebral 
circulation defect and multiple events in peripheral territories 
being more likely to be embolic. Also, young patients with 
sudden-onset neurological events and patients with underlying 
atrial fibriIIation, cardiomyopathy, or other cardiac disease are 
more likely to have a cardioembolic event as the cause of a 
vascular occlusive event rather than intrinsic vascular disease. 
TEE is mOre sensitive for identifying potential cardiac 
sources in a patient with an embolic event than TIE. However, 
if a potential cardiac source is found by TIE in a patient with 
an embolic event, the additive cost and inconvenience of TEE 
is probably not warranted. Conversely TEE is uniquely suited 
for detection of left atrial spontaneous contrast, left atrial 
thrombi, atrial septal aneurysms, and aortic atheromata. 
Indications for EcTlocardiograpily in Patients 
Witll Neurological Events or Other Vascular 
Occlusive Evmls Class 
1. :Patients of any age with abrupt occlusion of a I 
major peripheral or visceral artery. 
2. Younger patients (typically <45 years) with I 
cerebrovascular events. 
3. Older patients (typically >45 .rears) with I 
neurological events without evidence of 
cerebrovascular disease or other obvious cause. 
4. Patients for whom a clinical therapeutic I 
decision (anticoagulation, etc) will depend on 
the results of echocardiography. 
5. Patients with suspicion of embolic disease and lIa 
with cerebrovascular disease of questionable 
significance. 
6. Patients "ith a neurological event and intrinsic lIb 
cerebrovascular disease of a nature sufficient to 
cause the clinical event. 
7. Patients for whom the results of III 
echocardiography will not impact a decision to 
institute anticoagulant therapy or otherwise 
alter the approach to diagnosis or treatment. 
XII. Arrhythmias and Palpitation 
Arrhythmias can occur as primary electrophysiological ab-
normalities or as a complication of or in association with 
structural heart disease. The utility of echocardiography lies 
primarily in the identification of associated heart disease, the 
knowledge of which will influence treatment of the arrhythmia 
or provide prognostic information. Echocardiography can de-
tect an underlying cardiac disorder in approximately 10% of 
patients with atrial fibrillation who have no clinically suspected 
cardiac disease and in 60% of those with equivocal evidence of 
heart disease. 
In patients with benign arrhythmias such as atrial or 
ventricular premature beats, echocardiographic evaluation 
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should be reselved for those with clinical suspicion of struc-
tural heart disease. On occasion, echocardiography may be 
helpful in patients with a DDD pacemaker when Doppler 
studies are used to determine the settings at which stroke 
volume is optimized. 
Indications for EcllOcardiograplly ill Patienls With 
Arrhythmias and Palpitations Class 
1. Arrh~hmias with clinical suspicion of structural I 
heart disease. 
2. Arrhythmia in a patient with a family history of I 
a genetically transmitted cardiac lesion 
associated with arrhythmia such as tuberous 
sclerosis, rhabdomyoma, or hypertrophic 
cardiomyopathy. 
3. Evaluation of patients as a component of the I 
workup before electrophysiological ablative 
procedures. 
4. Arrhythmia requiring treatment. lIa 
S. TEE guidance of transseptai catheterization lIa 
and catheter placement during ablative 
procedures. 
6. Arrhythmias commonly associated with, but lib 
without clinical evidence of, heart disease. 
7. Evaluation of patients who have undergone lib 
radiofrequency ablation in the absence of 
complications. (In centers with established 
ablation programs, a postprocedural 
echocardiogram may not be necessary. ) 
8. Palpitation without corresponding arrhythmia ill 
or other cardiac signs or symptoms. 
9. Isolated premature ventricular contractions for III 
which there is no clinical suspicion of heart 
disease. 
Cardioversion for Patients With Atrial Fiblillation 
Echocardiography can help identifY patients with atrial 
fibrillation who are most likely to maintain sinus rhythm after 
cardioversion. LV dysfunction argues against long-term suc-
cess. Atrial size is a more controversial prognosticator. In 
subjects undergoing cardioversion for atrial fibrillation, it 
has been reported that exclusion of intra-atrial thrombus by 
TEE can obviate the need for extended precardioversion 
anticoagulation, allowing instead the use of heparin immedi-
ately before cardioversion and continuing coumadin for 
several weeks afterward until mechanical function of the 
atrium has been restored. Large multicenter trials are stilI 
ongoing to address this issue. It is also not clear how long 
atrial fibrillation must be present before the thrombus can 
form, so that there may be no difference in the danger of 
thrombus formation between recent-onset and chronic atrial 
fibrillation. 
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Indications for Ecllocardiograplly Before Cardioversion Cross 
1.. Patients requiring urgent (not emergent) I 
cardioversion for whom extended precanlioversion 
anticoagulation is not desirable. * 
2. Patients who have had prior cardioembolic I 
events thought to be related to intra-atrial 
thrombus.* 
3. Patients for whom anticoagulation is I 
contraindicated and for whom a decision about 
cardioversion will be influenced by TEE resuIts.* 
4. Patients for whom intra-atrial thrombus has I 
been demonstrated in previous TEE. * 
S. Evaluation of patient for whom a decision I 
concerning cardioversion will be impacted by 
knowledge of prognostic factors (such as LV 
function, coexistent mitral valve disease, etc). 
6. Patients with atrial fibrillation of <48 hours' lIa 
duration and other heart disease.* 
7. Patients with atrial fibrillation of <48 hours' lIb 
duration and no other heart disease. * 
8. Patients with mitral valve disease or lIb 
hypertrophic cardiomyopathy who have been on 
long-term anticoagulation at therapeutic levels 
before cardioversion. * 
9. Patients undergoing cardioversion from atrial lIb 
flutter. 
10. Patients requiring emergent cardioversion. III 
11. Patients who have been on long-term III 
anticoagulation at therapeutic levels and who do 
not have mitral valve disease or hypertrophic 
cardiomyopathy before cardioversion. 
12. Precardiover!iion evaluation of patients who have III 
undergone previous TEE and with no clinical 
suspicion of a significant interval change. 
*TEEonly. 
Syncope 
The role of echocarrliography in evaluation of patients with 
syncope is related to its capability to diagnose and quantitate 
obstructive lesions and identifY abnonnalities such as LV dysfunc-
tion that provide a substrate for malignant arrhythmias. There is 
little evidence that echocardiography is needed in the workup of 
a patient with no clinical evidence of underlying heart disease. 
Indications for Echocardiography ill tile Patiellt 
"With Syncope Class 
1. Syncope in a patient with clinically suspected I 
heart disease. 
2. Periexertional syncope. I 
3. Syncope in a patient in a high-risk occupation lIa 
(eg, pilot). 
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4. Syncope of occult etiology with no findings of lib 
heart disease on history or physical exam. 
S. Recurrent syncope in a patient in whom III 
previous echocardiograpbic or other testing 
demonstrated a cause of syncope. 
6. Syncope in a patient for whom there is no III 
ciinical suspicion of heart disease. 
7. Classic neurogenic s)''ncope. III 
Screening 
As a testing modality, echocardiography is safe, widely 
available, and accurate in identifying the presence of most 
structural heart disease. For echocardiography to be useful, thlO 
diseases screened for must be relatively frequent and when 
present must lead to a change in management that will 
favorably affect long-term outcome. Because of its cost and 
the many conditions echocardiography is capable of identify-
ing, only a few conditions meet these criteria. Examples 
include screening for heritable diseases of the heart and great 
vessels in relatives of affected individuals: for instance, hyper-
trophic cardiomyopathy and Marfan syndrome as well as other 
heritable conditions such as connective tissue diseases and 
tuberous sclerosis. 
Another indication for echocardiographic screening is in 
the evaluation of potential donor hearts for transplantation. 
Such screening can eliminate a donor's heart about 25% of the 
time. However, screening is not justified when asymptomatic 
cardiovascular disease is sought in large populations of pa-
tients at low risk for cardiovascular involvement. 
Using echocardiography to screen the asymptomatic adult 
competitive athlete for the existence of occult heart disease is 
not justified due to the low prevalence of cardiac cond 'ons in 
patients without clinIcal evidence of heart disease. 
Indicatio;IS for Echocardiography to Screen for 'he 
Prese1lce oj Cardiovascular Disease Class 
1. Patients with a family history of genetically I 
transmitted cardiovascular disease. 
2. Potential donors for cardiac transplantation. I 
3. Patients with phenotypic features of Marfan I 
syndrome or related connective tissue diseases. 
4. Baseline and reevaluations of patients I 
un~ergoing chemotherapy with cardiotoxic 
agents. 
5. Patients with systemic disease that may affect lib 
ihe heart. 
6. The general popidation. III 
7. Competitive athletes without clinical evidence of III 
heart disease. 
XIII. Echocardiograpby in the Critically III 
Echocardiography is extremely helpful for making the 
differentilil diagnosis in the hemodynamically unstable, criti-
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cally ill patient. Echocardiography is most helpful in acute 
ischemic syndromes, myocardial ischemic syndromes, hypoten-
sion of unknown cause, cardiac tamponade, aortic dissection, 
mechanical or infective complications of mechanical valves, 
and evaluation of the source of embolism. 
Patients in the intensive care unit are frequently on me-
chanical ventilation, cannot be appropriately positioned, or 
have postoperative dressings or chest tubes preventing ade-
quate TIE. In these cases TEE is often required. An in-
creasing body of evidence in the literature supports the value 
of TEE when TIE is inadequate and documents that the 
findings on TEE often result in a change in treatment. Even 
though cardiac output can be measured by echocardiography, 
it is not likely to replace thermodilution-determined cardiac 
outputs by pulmonary artery catheterization because continu-
ous clinical measurements are not feasible with echocardiog-
raphy. 
The Trauma Patient 
Both TIE and. TEE are useful for the severely injured 
patient when cardiac, perlcardial, mediastinal, or major in-
trathoracic vascular injury has occurred. Myocardial con-
tusion or rupture, pericardial effusion anci tamponade, major 
vascuiar injury, septal defects or fistulae, and valvular regurgi-
tation cim all occur in both penetrating and non penetrating 
injury. 
Unexplained hypotension is well addressed by echcicardiog-
raphy. TIE is very successful in identifying cardiac trauma and 
pericardial fluid in the patient with penetrating chest injury, 
thus avoiding the necessity of an exploratory thoracotomy or 
subxiphoid pericardiotomy. Immediate evaluation in the emer-
gency department can result in prompt appropriate treatment, 
including emergency thoracotomy. With traumatic rupture of 
the aorta, aortography is the gold standard, but TEE is 
becoming the procedure of choice, depending on the expertise 
of the echocardiographer and immediate availability of the 
study. 
Conditions and Settings in Which Transesophageal 
Echocardiography Provides the Most Definitive 
Diagnosis in the Critically III and Injured 
• The hemodynamically unstable patient with suboptimal 
TIE images. 
.. The hemodynamically unstable patient on a ventilator. 
• Major trauma or postoperative patients (unable to be 
positioned for adequate TIE). 
o Suspected aortic dissection. 
• Suspected aortic injury. 
• Other conditions in which TEE is superior (see section on 
valvular disease). 
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IlIdicatiollS for Echocartiiograplzy ill the 
Critically III Class 
1. The hemodynamically unstable patient. I 
2. Suspected aortic dissection (TEE). I 
3. The hemodynamically stable patient not III 
expected to have cardiac disease. 
4. Reevaluation follow·up studies on III 
hemodynamically stable patients. 
Indications for Echocartiiography ill the 
Critically Injured* Class 
1. Serious blunt or penetrating chest trauma I 
(suspected pericardial effusion or tamponade). 
2. Mechanically ventilated multiple. trauma or chest I 
trauma patient. 
3. Suspected preexisting valvular or myocardial I 
disease in the trauma patient. 
4. The hemodynamically unstable multiple.injury I 
patient without obvious chest trauma but with a 
mechanism of injury suggesting potential cardiac 
or aortic injury (deceleration or crush). 
5. Widening of the mediastinum, postinjury I 
suspected aortic injury (TEE). 
6. Potential catheter, guidewire, pacer electrode, or I 
pericardiocentesis needle injury with or without 
signs of tamponade. 
7. Evaluation of hemodynamics in multiple.trauma IIa 
or chest trauma patients with pulmonary artery 
catheter monitoring and data disparate with 
clinical situation. 
S. Follow.up study on victims of serious blunt or IIa 
penetrating trauma. 
9. Suspected myocardial contusion in the III 
hemodynamically stable patient with a normal 
ECG. 
*The use of TIE or TEE includes Doppler techniques when 
indicated and available and with appropriately trained and 
experienced sonographer and interpreter. 
TEE is indicated when TIE images are suboptimal. TEE often 
provides incremental information. 
XIV. Doppler Echocardiography in the Adult 
Patient With Congenital Heart Disease 
The adult patient with congenital heart disease is seen by the 
cardiologist either because the problem was not discovered in 
childhood or more often because the patient was previously 
diagnosed with inoperable congenital heart disease or has under-
gone one or more palliative or corrective surgical procedures. The 
only patients with congenital heart disease who are considered 
"cured" are those with repaired patent ductus arteriosus and 
some patients with repaired atrial septal defects; thus, most 
patients must be followed periodically to evaluate residual defects 
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and detect the late complications that occur even in the patient 
with a condition that has been "surgically corrected." 
Indications for Ec/lOcardiography ill the Adult Patient 
With Congenital Heart Disease Class 
1. Patients with clinically suspected congenital I 
heart disease, as evidenced by signs and 
symptoms such as a murmur, cyanosis, or 
unexplained arterial desaturation, and an 
abnormal ECG or radiograph suggesting 
congenit.'ll heart disease. 
2. Patients with known congenital heart disease on I 
follow·up when there is a change in clinical 
findings. 
3. Patients with known congenital heart disease for I 
whom there is uncertainty as to the original 
diagnosis or when the precise nature of the 
structural abnormalities or hemodynamics is 
unclear. 
4. Periodic echocardiograms in patients with known I 
congenital heart lesions and for whom 
ventricular function and atrioventricular valve 
regurgitation must be followed (eg, patients with 
a functionally single ventricle after Fontan 
procedure, transposition of the great vessels after 
Mustard procedure, L·transposition and 
ventricular inversion, and palliative shunts). 
5. Patients with known congenital heart disease for I 
whom following pulmonary artery pressure is 
important (eg, patients with moderate or 
ventricular septal defects, atrial septal defects, 
single ventricle, or any of the above with an 
additional risk factor for pulmonary 
hypertension). 
6. Periodic echocardiography in patients with I 
surgically repaired (or palliated) congenital 
heart disease with the following: change in 
clinical condition or clinical suspicion of residual 
defects, LV or RV function that must be followed, 
or when there is a possibility of hemodynamic 
progression or a history of pulmonary 
hypertension. 
7. To direct interventional catheter valvotomy, I 
radiofrequency ablation valvotomy interventions 
in the presence of complex cardiac anatomy. 
S. A follow.up Doppler echocardiographic study, lIb 
annually or once every 2 years, in patients with 
known hemodynamically significant congenital 
heart disease without evident change in clinical 
condition. 
9. Multiple repeat Doppler echocardiography in III 
patients with repaired patent ductus arteriosus, 
atrial septal defect, ventricular septal defect, 
coarctation of the aorta, or bicuspid aortic valve 
without change in clinical condition. 
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10. Repeat Doppler echocardiography in patients III 
with known hemod;'Damically insignificant 
congenital heart lesions (eg, small atrial septal 
defect, small ventricular septal defect) without a 
change in clinical condition. 
Late Postoperative Complications in Patients With 
Congenital Heart Disease 
The danger of infective endocarditis is present in most 
patients with congenital heart disease when there is a high-
velocity jet that traumatizes the endocardium. This in.c1udes 
patients with residual ventricular septal defects or palliative 
shunts or valvular stenosis or insufficiency, especially left-sided. 
Residual pulmonary hypertension due to pulmonary vascu-
lar disease can remain after closure of a large atrial or 
ventricular septal defect, atrioventricular canal, or patent 
ductus arteriosus. Even after repair, pulmonary hypertension 
can become progressively severe. Late complications in pa-
tients with specific congenital heart lesions who have under-
gone surgery are discussed in the full text of the guidelines (see 
"Echocardiography in the Critically III"). 
xv. Echocardiography in the Pediatric Patient 
Echocardiography has become the definitive diagnostic 
method for the recognition and assessment of congenital and 
acquired heart disease in the pcdiatric population. Reevalua-
tion by echocardiography is frequently used to monitor cardio-
vascular adaptation to surgical repair or palliation and to 
identify recurrence of abnormalities. 
Congenital structural heart disease is the most common type 
of cardiovascular disease in the pediatric population. However, 
acquired heart disease such as rheumatic heart disease, Kawasaki 
disease, infective endocarditis, postinfection or other etiologies of 
cardiomyopathy, and hypeltrophic cardiomyopathy all contribute 
to the cardiovascular morbidity in this population. 
Resource Utilization and Age 
Guidelines for pediatric e.:hocardiography must be stratified 
by age to accommodate the unique physiology of the neonate, the 
neonate's transitional circulation with its rapid changes in pulmo-
nary resistance, closure of the ductus arteriosus, and the frequent 
occurrence of pulmonary disease. Perinatal physiological changes 
may mask the presence of hemodynamically important cardiovas-
cular lesions. Neonates with congenital anomalies of other organs 
needing urgent surgery should be screened by echocardiography 
to rule out associated cardiac anomalies, which will facilitate 
decision making and therapy. 
Congenital Cardiovascular Disease in the Neonate 
Structural congenital cardiovascular disease. Echocardiog-
raphy provides essential structural information in all forms of 
cardiac and great vessel disease in pediatric patients. Doppler 
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echocardiography provides important physiological information 
that combined with anatomic data is sufficient to guide therapeu-
tic management in some diagnostic categories. Reevaluation 
examination allows tracking of hemodynamic changes occurring 
in the transitional circulation of the newborn and provides 
information to guide medical or surgical intelVention. 
Cardiopulmonary disease. Premature infants may have 
respiratory failure due to a combination of processes: lung 
immaturity, hyaline membrane disease, persistence of ductus 
arteriosus, inflammatory disease, or congenital heart disease. 
Doppler echocardiography indicates the patency of the ductus 
arteriosus, direction and degree of shunting at the ductal level, 
and assessment of pulmonary artery pressure and its conse-
quences. Differentiation of primary pulmonary hypertension 
from cyanotic heart disease requires echocardiography. 
Indications for Neol/atai EcllOcardiography Class 
1. Cyanosis, respiratory distress, cOlliestive heart I 
failure, 0:.' abnomlal arterial pulses. 
2. Chromosomal abnormality or major I 
extra cardiac abnormality associated with a high 
incidence of coexisting cardiac abnormality. 
3. Lack of expected improvement in I 
canJiopulmonary status in a premature infant 
with a clinical diagnosis of pulmonary disease. 
4. SystemiC maternal disease associated with I 
neonatal comorbidity. 
5, Loud or abnormal murmur or other abnormal I 
cardiac finding in an infant. 
6. Presence of a syndrome associated with I 
cardiovascular disease and dominant 
inheritance or multiple affected family members. 
7. Pre!lence of a syndrome associated \\ith heart I 
disease, with I)r without abnormal cardiac 
findings, for which an urgent management 
decision is needed. 
8. Cardiomegaly on chest radiograph. I 
9. Dextrocardia, abnormal pulmonary or visceral I 
situs by clinical, electrocardiographic, or 
radiographic examination. 
10. Arrhythmias or other abnormalities on standard I 
ECG suggesting structural heart disease or 
peripartum myocardial injury. 
11. Clinical suspicion of residual or recurrent I 
abnonnality, poor ventricular function, 
pulmonary artery hypertension, thrombus, 
sepsis, or pericardial effusion after 
cardiovascular surgical therapy for congenital 
heart disease. 
12. Nonimmunologic fetal hydrops. I 
13. Follow-up assessment of a neonate with patent I 
ductlls arteriosus who has undergone medical or 
surgical intervention. 
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14. Short, soft murmur at the lower left sternal lIa 
border in the neonate. 
15. Failure to thrive in the absence of definite Ua 
abnormal clii:lical findings. 
16. Presence of a syndrome associated with a high lIb 
incidence of congenital heart disease for wltich 
there are no abnormal cardiac findings and no 
Iirgency of management decisions. 
17. History of nonsustained fetal ectopy in the III 
absence of postpartum arrhythmias. 
Ccngenila[ Cardiovascular Disease in the Infant, 
Child, and Adolescent 
In these age groups cardiovascular disease includes anom-
alies of the cardiac anatomy, function, morphogenesis, and 
rhythm. These problems often present as an asymptomatic 
cardiac murmur; however, murmurs in this age group are more 
commoniy functional than pathological. Hbtory and physical 
examination by a skilled observer is usually sufficient to 
distinguish a functional murmur from a pathological murmur 
and more cost-effective than a referral for an echocardiogram. 
Where the clinical findings are ambiguous, organic pathology 
can be ruled out by Doppler echocardiography. 
Structural cardiovascular disease. The abnormalities found 
in these age groups are identical to those encountered in 
the neonatal period. Doppler echocardiography can fully char-
acterize a cardiac lesion once an abnormality is suspected. 
Echocardiography provides important information in patients 
with connective tissue disorders such as Marfan syndrome and 
Ehlers-Danlos syndrome. 
Indications for Echocardiography ill the Illfallt, Child, 
and Adolescellt Class 
1. Atypical or pathological murmur or other I 
abnormal cardiac finding in an infant or older 
child. 
2. Cardiomegaly on chest radiograph. I 
3. Dextrocardia, abnormal pulmonary or visceral I 
situs on clinical, electrocardiographic, or 
radiographic examination. 
4. Patients with a knO'Ml cardiac defect to assess I 
timiQg of medical or surgical therapy. 
5. Immelliate preoperative evaluation for cardiac I 
surgery of a patient with a known cardiac defect 
to guide cardiac surgical management and 
infonn the patient and family of risks of surgery. 
6. Patient with known cardiac lesion and change in I 
physical finding. 
7. Postoperative congenital or acquired heart I 
disease with clinical suspicion of residual or 
recurrent abnormality, poor ventricular function, 
pulmonary artery hypertension, thrombus, 
sepsis, or pericardia I clfusion. 
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8. Presence of a syndrome associated with I 
cardiovascular disease and dominant inheritance 
or multiple affected family members. 
9. Patients with a family hi3tory of genetically I 
transmitted myocardial disease, with or without 
abnormal cardiac finding. 
10. Phenotypic findings of Marfan syndrome or I 
Ehlers-Danlos syndrome. 
11. Baseline and follow-up examinations of patients I 
with neuromuscular disordel'S having known 
myocardial involvement. 
12. Presence of a syndrome associated with a high 
inddence of congenital heart disease when there 
are no abnormal cardiac findings. 
13. Exercise-induced pre.cGidial chest :>ain or syncope. I 
14. "Atypical," "non-vasodepressor" syncope without I 
other cause. 
15. Failure to thrive in the absence of definite Hb 
abnonnal clinical findings. 
16. In a child or adolescent, an asymptomatic heart m 
munnur identified by an eXl)erienced observer as 
functional or an insignificant cardiovascular 
abnormality. 
17. In an otherwise asymptomatic child or adolescent, UJ 
thest pain identified by an experienced observer 
as musculoskeletal in origin. 
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Arrhythmias/conduction disturbances. Arrhythmias in the 
pediatric population may be associated with Ebstein's anom-
aly, cardiac tumor, cardiomyopathy, MVP, glycogen storage 
disease, or stimulation from migrated central venous catheters. 
Asymptomatic arrhythmias such as supraventricular premature 
beats or brief runs of supraventricular tachycardia are rarely 
associated with pathology. 
IndicatiollS for Echocardiogrllphy in Pediatric Patients 
With A.7hythmias/Cotufucti(11l Disturbances Class 
1. Arrhythmia in the presence of an abnlrmal I 
cardiac finding. 
2. Arrhythmia in a patient with a family history of I 
a genetically transmitted cardiac lesion 
associated with arrhythmia, :>uch as tuberous 
sclerosis ()r hypertrophic cardiomyopathy. 
3. Compiete atrioventricular block or advanced I 
secolld-degree atriove.\tricular block. 
4. Complete or high-degree secondary I 
atrioventricular block. 
S. Anhythmia requiring treatment. I 
6. Venhicular arrhythmia in a p::tient referred for IIa 
evaluation for competitive sports. 
7. Evidence of preexcitation on ECG. lIa 
8. Preexcitation on ECG in the absence of fib 
abnormal cardiac findings. 
9. Recurring arrhythmia not requiring treatment in llb 
the presence of normal findings on examin:!tior.. 
878 ECHOCARDIOGRAPHY GUIDELINES 
Ace/AHA TASK FORCE 
10, Sinus arrhythmia or isolated extrasystoles in a ill 
child with otherwise normal ('ardiac findings 
and no family history of a genetically 
transmitted abnormality associated with 
arrhythmia. 
Acquired cardiovascular disease. Acquired cardiovascular 
disease occurs with systemic disease processes associated 
with inflammation, hypertension due to renal disease, cardio-
toxic therapy, pulmonary disease, and post-heart transplanta-
tion, Echocardioglaphy provides information about cardiac 
chamber size and function, atrioventricular and semilunar 
valve function, intracardiac masses, and the presence of peri-
cardial disease. Kawa~aki disease, endocarditis, rheumatic 
fever, human immunodeficiency viral (HIV) disease, hypertro-
phic cardiomyopathy, dilated cardiomyopathy, and cardiac 
involvement in neuromuscular disease are all seen in child-
hood. 
Indications for Ec1lOcardiography in Pediatric Acquired 
Cardiovascular Disease Class 
1. Baseline studies and reevaluation as clinically I 
indicated on all pediatric patients with 
suspected or do(;Umented Kawasaki disea8e, 
myopencarditfs, HIV, or rheumatic fever. 
2. Postcardiac or cardiopulmonary transplant to I 
monitor for signs ot' acute or chronic rejecticn, 
thrombus; and cardiac growth. 
3. Baseline and reevaluation examinations of I 
patients receiving cardiotoxic therapeutic 
agents. 
4. Patients with clinical evid(;nce of myor.ardial I 
disease. 
5. Patients with severe renal disease 'Ind an I 
abnormal cardiac finding. 
6. Donors undergoicg evaluation for cardiac I 
transplantation. 
7. An acutely ill child with suspected bacterial lIa 
sepsis ar rickettsial disease. 
S. Follow-up examinations aiter acute rheumatic fib 
fever in patients with normal cardiac findings, 
9. A single late follow-up study after acute Db 
pericarditis mth no evidence of r~currence or 
chronic pericardial disease. 
10. Long-term follow-up studies in patients with m 
Kawasaki disease who have no coronary 
abnormalities during the acute phase of the 
disease process. 
Pulmonary diseasl:s. Children with upper airway or 
chronic lung disease may have pulmonary artery hypertension, 
the magnitude of which can be assessed by Doppler echo car-
diography. 
Indications for Ec1lOcardiography in Pediatric 
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Cardiopulmonary Disease Class 
1. Any patient with clinical findings of pulmonary I 
artery hypertension. 
2. Baseline sturly of patients with cystic fihrosis nil 
and no findings of cor pulmonale. 
Thrombus/tumor, Thromboembolism, including ~troke in 
childhood, can result from intracardiac thrombus, tumor, or 
vegetation. Because children have a lower incidence of vascu-
lar disease as a cause of stroke or loss of pulse, the yield of 
echocardiography in finding an intracardiac cause may be 
somewhat higher than for adults. Patients with Fontan proce-
dures, dilated cardiomyopathy, or any other causes of severely 
reduced ventricular function as well as indwelling catheters are 
all predisposed to thrombus formation. Atrial myxoma and 
infective endocarditis are both causes of systemic embolization 
in children. Echocardiographic screening for cardiac tumor is 
indicated in the fetus or newborn with clinical evidence or 
family history of tuberous sclerosis. Repeat screening later in 
childhood is also warranted because these tumors can appear 
at any time in childhood. 
Indications for Echocardiography in Pediatric 
Thromboembolic Disease States Class 
1. Thromboemholic event in an infant, child, £ir I 
adolescent. 
2. Finding or family history of tuberous sclerosis. I 
3. Appearance of sepsis, cyanosis, or right-heart I 
failure in a patient with a long-standing 
indwelling catheter. 
4. Systemic embolization or acute-onset I 
hypertension in a patient with right-to-Ieft-
shunting and an indwelling catheter. 
5. Superior vena caval syndrome in the presence of I 
central venous catheter. 
6. Patient with indwelUug ca~heter and fever but fib 
without evidence of pulmonary or systemic 
embolization, 
7. Routine surveillance of asymptomatic patients m 
with indwelling catheter. 
Transesophageal Echocardiograp.~v 
TIE using high-frequency imaging probes offers excellent 
resolution of intracardiac aAld paracardiac structures in the 
infant and young child. TEE adds important infonnation on 
these structures in the older pediatric patient and in subjects 
during and after thoracic instrumentation. TEE may be used in 
concert with cardiac catheterization to limit the quantity of 
radiographic contrast material, especially in complex cases and 
patients with pulmonary artery hypertension. Certain interven-
tions such as balloon atrial septostomy, placement of intracar-
diac devices, and ;adiofi"equency ablation for arrhythmias are 
facilitated by TEE. Because the potential for airway compro-
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mise and coexistence of complex gastroesophageal anomalies 
is increased in smaller patients, TEE should only be performed 
by operators skilled in TEE and trained in the care of infants 
and children. 
Indications for Transesopllageal Echocardiography in 
Pediatric Patiellts 
1. Any patient with congenital or acquired heart 
diseas'2 needing echocardiograp~.y when 
significant diagnostic infonnation cannot be 
obtained by TIE. 
2. Monitoring and guidance during Cllrdiothoracic 
procedures witen there is It risk for residual 
shunting, valvular insufficiency, obstruction, or 
myocardial dysfundion. 
3. Guidanc(; of catbeter/device placement during 
inten'entimlal catheterization/radiofrequency 
ablation in patients with congenital nClJrt 
disease. 
4. Study of patients with intra-a~ri~l bailie in 
whom the :,otential for throinbus is of concern 
because ot elevated centra! venllus pressures, 
atrial chambe.· dilation, increasing cyanosis, ar 
tbe appearance of arrhythmia. 
5. Patients with 'ong-tenn placement of 
in.travascular del-ieer. in \VIlom thrombus or 
veg~tation is suspected. 
6. Patients wit!t a prostl>etic valve in whom 
thrombus or vegetation is suspected. 
7. Any patient with suspec~ed ecdocardilis and 
inadequate transthoracic acoustiral window. 
8. JJerfonning TEE in a patient who has not 
previuusly had careful study by TIE. 
9. Patients with structural esophageal abnonnality. 
Fetal Echocardiography 
Class 
I 
i 
I 
I 
I 
I 
I 
m 
ill 
Definition of fetal cardiac structures is currently possible at 
10 to 12 weeks of gestation with the use of vaginal probes with 
high-resolution transducers. With current technologies, accu-
rate segmental analysis of cardiac structures and blood flow 
across valves, shunts, and the ductus is possible with a conven-
tional transabdominal approach by 16 to ] 8 wel;l~s of gestation. 
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Patients are referred for fetal echocardiography because of 
an abnormality of structure or rhythm noted on ultrasour.-i 
examination or because the patient is in n high-risk group for 
fetal heart disease. Treatment of the patient is facilitated by 
the early recognition of the exact nature of the cardiac problem 
in the fetus. The correct diagnosis may be difficult because of 
fetal physiology, the effect on flow across defects and valves, 
inability to see the fetus for orientation reference, aod inability 
to examine the fetus for clinical findings. For these reasons, 
fetal echocardiography should be performed only by trained 
fetal echocc:rdiographers. Such experts may be pediatric car-
diologists, cbstetricians, or radiologists with 3pecia\ training. 
Indications for Fellli Echocardiograplzy Class 
1, Abnormal-appearing heart 011 general fetal I 
ultrasound elillmination. 
2. Fetal tachycardia, bradycardia, or persistent I 
irregular rhythm on clinical or screening 
ultrasound examination. 
3. Matemal/family risk factors for cardiovascular I 
disease, such as a parent, sibling, or first-degree 
relative with congenital heart disea:.e. 
4. Maternal diabetes. I 
5. Maternal systemic lupus erythematosus. I 
6. Teratogen exposure during a vulnerable period. I 
7. Other fetal system abnormalities (including I 
chromosnmal). 
8. Performance of transplacental therapy or I 
presence of a history of significant but 
intermittent atThythmia. Reevaluation 
examinations are required in these conditions. 
9. Fetal distress Qr dysfunction of unclear etiology. fia 
10. Previous fiist{)JY of multiple fetal losses. Db 
11. Multiple gestation. fib 
12. I..ow·risk pmgmmdes with normal anatomic m 
findings on ultrasound examination. 
13. Occas:onal premature contractions witbol\t ill 
sustained tachycardia 01' signs of dysfun(~tiol1 or 
distress. 
14. Presence of a noncardiovascular system m 
abnormality when evaluation of the 
cardiovascular system will not alter either 
management decisions or fetal outcome. 
